Stay updated on Tesofensine/Metoprolol in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the Tesofensine/Metoprolol in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tesofensine/Metoprolol in Type 2 Diabetes Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page's revision metadata was updated to v3.3.2; the previous v3.2.0 entry was removed.
    Difference
    0.1%
    Check dated 2025-11-24T21:18:54.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page no longer displays a government funding lapse notice regarding NIH operations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T18:33:10.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Type 2 diabetes and related topics were removed from the page.
    Difference
    0.7%
    Check dated 2025-11-03T13:17:12.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Removed MedlinePlus Genetics topic: Type 2 diabetes.
    Difference
    0.5%
    Check dated 2025-10-20T07:21:04.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page has been expanded to include a MedlinePlus Genetics topic on Type 2 diabetes, broadening its coverage of genetic information related to diabetes.
    Difference
    0.5%
    Check dated 2025-10-13T05:30:08.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Update includes a critical operating-status notice and an upgraded version identifier to v3.2.0, replacing the previous v3.1.0.
    Difference
    6%
    Check dated 2025-10-06T04:14:47.000Z thumbnail image

Stay in the know with updates to Tesofensine/Metoprolol in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tesofensine/Metoprolol in Type 2 Diabetes Clinical Trial page.